[Effecting factors on survival in patients taking thrombolytic treatment due to massive pulmonary embolism].
Hatipoğlu
Osman Nuri
ON
Trakya Universitesi Tıp Fakultesi, Göğüs Hastalıkları Anabilim Dalı, Edirne. osmanh@trakya.edu.tr
Perinçek
Gökhan
G
Cakır Edis
Ebru
E
Tabakoğlu
Erhan
E
Altıay
Gündeniz
G
D000328:Adult; D000368:Aged; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D017052:Hospital Mortality; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016016:Proportional Hazards Models; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000401:mortality*; D012189:Retrospective Studies; D012307:Risk Factors; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D013997:Time Factors
D005343:Fibrinolytic Agents; D013300:Streptokinase
Masif pulmoner emboli nedeniyle trombolitik tedavi uygulanan hastalarda yaşam süresi üzerine etki eden faktörler.